Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cancer
MedTech
Exact Sciences rolls out Cancerguard multi-cancer blood test
Priced at $689, Cancerguard will open up to broad consumer access through its own telehealth portal next month.
Conor Hale
Sep 11, 2025 1:00pm
Investor syndicate takes majority stake in HistoSonics
Aug 7, 2025 1:16pm
Grail plans to submit updated Galleri blood test to FDA in 2026
Jun 18, 2025 11:45am
Caris Life Sciences ups IPO to raise $494M
Jun 18, 2025 11:00am
Fierce Pharma
BioNTech to wind down cell therapy manufacturing in Maryland
Jun 18, 2025 10:23am
Quest Diagnostics taps MD Anderson for cancer risk blood test
Jun 10, 2025 2:11pm
